Healthcare -
Biotechnology - NASDAQ - US
$ 57.18
1.35 %
$ 7.27 B
Market Cap
18.93
P/E
HALO - LONG-TERM DEBT
Long-term Debt HALO - Halozyme Therapeutics, Inc.
1.5 B
LAST VALUE
37.95%
2 YEAR CAGR
112.17%
5 YEAR CAGR
40.57%
10 YEAR CAGR